Join to View Full Profile
9500 Euclid AveCleveland, OH 44195
Phone+1 216-445-6025
Dr. Olman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ChicagoFellowship, Pulmonary Disease and Critical Care Medicine, 1986 - 1987- University of ChicagoResidency, Internal Medicine, 1983 - 1986
New York University School of MedicineClass of 1983
Certifications & Licensure
CA State Medical License 1987 - Present
OH State Medical License 2009 - 2026
AL State Medical License 1993 - 2009
IL State Medical License 1983 - 1987
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 1 citationsNocturnal Hypoxemia Is Associated with Sarcopenia in Patients with Chronic Obstructive Pulmonary Disease.Amy H Attaway, Reena Mehra, Joe G Zein, Umur Hatipoğlu, Megan Grund
Annals of the American Thoracic Society. 2024-09-01 - 7 citationsMilk fat globule-epidermal growth factor 8 (MFGE8) prevents intestinal fibrosis.Sinan Lin, Jie Wang, Pranab K Mukherjee, Ren Mao, Gail West
Gut. 2024-06-06 - 2 citationsTRPV4 Regulates the Macrophage Metabolic Response to Limit Sepsis-induced Lung Injury.Erica M Orsini, Sanjoy Roychowdhury, Mahesha Gangadhariah, Emily Cross, Susamma Abraham
American Journal of Respiratory Cell and Molecular Biology. 2024-06-01
Press Mentions
Mechanical Signaling Cascade Central to Fibrotic Scar Tissue Development DefinedNovember 13th, 2019
TRPV4 Regulates the Host Defense Response to InfectionMay 24th, 2018
Grant Support
- Profibrotic Mechanisms of the TRPV4-PI3K-gamma Protein ComplexCLEVELAND CLINIC LERNER COM-CWRU2021–2025
- Deranged Coagulation And Fibrinolytic Cascades In Idiopathic Pulmonary FibrosisNational Heart, Lung, And Blood Institute2010–2012
- Mechanisms Of U-Par-Mediated Lung Fibroblast MotilityNational Heart, Lung, And Blood Institute2004–2007
- Mechanisms Of PAI1 Regulation By Lung Matrix MoleculesNational Heart, Lung, And Blood Institute1999–2003
- Scleroderma Lung StudyNational Heart, Lung, And Blood Institute1999–2001
- Oral Cyclophosphamide VS Oral Placebo In SSC AlveolitisNational Heart, Lung, And Blood Institute2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
